SK Biopharmaceuticals-Q3 earnings

SK Biopharmaceuticals remains in red in Q3

SEOUL, Nov. 11 (Yonhap) -- SK Biopharmaceuticals Co. on Thursday reported its third-quarter net loss of 44.3 billion won (US$37.3 million), remaining in the red compared with a year ago.

The company said in a regulatory filing that it continued to post an operating loss of 49.9 billion won for the July-September period, compared with a loss of 63 billion won a year earlier. Revenue rose 510.5 percent to 24 billion won.

(END)

[ⓒ K-VIBE. 무단전재-재배포 금지]